Dalmevin

Dalmevin contains vildagliptin, an oral medication used to manage type 2 diabetes. It helps control blood sugar levels by increasing insulin production.

Dalmevin is primarily used to treat type 2 diabetes. It works by increasing the levels of insulin produced by the pancreas, which helps to lower blood sugar levels. This medication is often prescribed as part of a comprehensive diabetes management plan, which may include diet and exercise.

Common effects of Dalmevin may include headaches, dizziness, and gastrointestinal discomfort. Some users might experience mild nausea or vomiting. These effects are generally temporary and should subside as the body adjusts to the medication.

Dalmevin should be used with caution in individuals with a history of kidney or liver problems. It is important to follow the prescribed dosage and consult a healthcare provider before starting or stopping the medication. Always store Dalmevin in a cool, dry place away from direct sunlight.

Dalmevin may interact with certain medications, including other diabetes treatments, blood thinners, and nonsteroidal anti-inflammatory drugs (NSAIDs). It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be limited while using Dalmevin.